Studies on the centrally mediated hypotensive activity of guanabenz.

[1]  T. Baum,et al.  Central and peripheral contribution to the antihypertensive action of indoramin. , 1975, European journal of pharmacology.

[2]  T. Baum,et al.  Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamine , 1975, Neuropharmacology.

[3]  Mcmahon Fg,et al.  Study of a new antihypertensive (guanabenz). , 1974 .

[4]  D. Nash.  Clinical trial with guanabenz, a new antihypertensive agent. , 1973, Journal of clinical pharmacology.

[5]  K. Fuxe,et al.  Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline receptor stimulation. , 1973, European journal of pharmacology.

[6]  A. Caputi,et al.  Cardiovascular profile of BR 750 (2,6-dichlorobenzylideneaminoguanidine acetate). , 1973, Il Farmaco; edizione pratica.

[7]  P. A. Zwieten.  The central action of antihypertensive drugs, mediated via central α ‐receptors , 1973 .

[8]  T. Baum,et al.  Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine. , 1973, Neuropharmacology.

[9]  S. Fénard,et al.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. , 1973, Arzneimittel-Forschung.

[10]  H. Aars.  Effects of clonidine on aortic diameter and aortic baroreceptor activity. , 1972, European journal of pharmacology.

[11]  D. Clement,et al.  Comparison of Afferent Activity of Canine Aortic and Sinus Nerves , 1972, Circulation research.

[12]  S. Fénard,et al.  New evidence for an -andrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine. , 1972, European journal of pharmacology.

[13]  T. Baum,et al.  Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678. , 1970, Neuropharmacology.

[14]  R. V. Van Pelt,et al.  General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678). , 1970, The Journal of pharmacology and experimental therapeutics.

[15]  J. Giudicelli,et al.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. , 1968, European journal of pharmacology.

[16]  F. N. David,et al.  Principles and procedures of statistics. , 1961 .

[17]  H. Jasper,et al.  A stereotaxic atlas of the diencephalon of the cat , 1960 .